APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Huntington Disease Medications

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Huntington Disease Medications Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 174000270328 December 2025196 pages

Choose your research edition.

Industry ResearchHuntington Disease Medications Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal Huntington Disease Medications Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Huntington Disease Medications Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Huntington Disease Medications Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Huntington Disease Medications Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Huntington Disease Medications market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Huntington Disease Medications is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Huntington Disease Medications is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Huntington Disease Medications is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Huntington Disease Medications is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Huntington Disease Medications include Teva, Sandoz, Mylan, Zydus, Sun Pharmaceutical, Neurocrine Biosciences, Lupin, Hetero and Dr. Reddy's Laboratories, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Huntington Disease Medications market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Huntington Disease Medications and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Huntington Disease Medications sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Huntington Disease Medications market size, projected growth trends, production technologies, key applications, and end-use industries.

Huntington Disease Medications Segment by Company

Teva

Sandoz

Mylan

Zydus

Sun Pharmaceutical

Neurocrine Biosciences

Lupin

Hetero

Dr. Reddy's Laboratories

Chartwell Pharmaceuticals

Bionpharma

Bausch Health

Apotex

Actavis Laboratories

Huntington Disease Medications Segment by Type

Deutetrabenazine

Tetrabenazine

Valbenazine

Others

Huntington Disease Medications Segment by Application

Hospital and Clinic

Pharmacy

Other

Huntington Disease Medications Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Huntington Disease Medications market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Huntington Disease Medications and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Huntington Disease Medications.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Huntington Disease Medications market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Huntington Disease Medications manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Huntington Disease Medications in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Huntington Disease Medications in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Huntington Disease Medications Industry Trends Table 2. Huntington Disease Medications Industry Drivers Table 3. Huntington Disease Medications Industry Opportunities and Challenges Table 4. Huntington Disease Medications Industry Restraints Table 5. Global Huntington Disease Medications Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Huntington Disease Medications Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Huntington Disease Medications Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Huntington Disease Medications Sales Market Share by Manufacturers Table 9. Global Huntington Disease Medications Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Huntington Disease Medications Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Huntington Disease Medications Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Huntington Disease Medications Manufacturers, Product Type & Application Table 13. Global Huntington Disease Medications Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Huntington Disease Medications by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Deutetrabenazine Table 17. Major Manufacturers of Tetrabenazine Table 18. Major Manufacturers of Valbenazine Table 19. Major Manufacturers of Others Table 20. Global Huntington Disease Medications Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 21. Global Huntington Disease Medications Sales by Type (2021-2026) & (K Units) Table 22. Global Huntington Disease Medications Sales by Type (2027-2032) & (K Units) Table 23. Global Huntington Disease Medications Sales Market Share by Type (2021-2026) Table 24. Global Huntington Disease Medications Sales Market Share by Type (2027-2032) Table 25. Global Huntington Disease Medications Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 26. Global Huntington Disease Medications Revenue by Type (2021-2026) & (K Units) Table 27. Global Huntington Disease Medications Revenue by Type (2027-2032) & (K Units) Table 28. Global Huntington Disease Medications Revenue Market Share by Type (2021-2026) Table 29. Global Huntington Disease Medications Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Hospital and Clinic Table 31. Major Manufacturers of Pharmacy Table 32. Major Manufacturers of Other Table 33. Global Huntington Disease Medications Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 34. Global Huntington Disease Medications Sales by Application (2021-2026) & (K Units) Table 35. Global Huntington Disease Medications Sales by Application (2027-2032) & (K Units) Table 36. Global Huntington Disease Medications Sales Market Share by Application (2021-2026) Table 37. Global Huntington Disease Medications Sales Market Share by Application (2027-2032) Table 38. Global Huntington Disease Medications Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 39. Global Huntington Disease Medications Revenue by Application (2021-2026) & (K Units) Table 40. Global Huntington Disease Medications Revenue by Application (2027-2032) & (K Units) Table 41. Global Huntington Disease Medications Revenue Market Share by Application (2021-2026) Table 42. Global Huntington Disease Medications Revenue Market Share by Application (2027-2032) Table 43. Global Huntington Disease Medications Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 44. Global Huntington Disease Medications Sales by Region (2021-2026) & (K Units) Table 45. Global Huntington Disease Medications Sales Market Share by Region (2021-2026) Table 46. Global Huntington Disease Medications Sales Forecasted by Region (2027-2032) & (K Units) Table 47. Global Huntington Disease Medications Sales Forecasted Market Share by Region (2027-2032) Table 48. North America Huntington Disease Medications Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 49. North America Huntington Disease Medications Sales by Country (2021-2026) & (K Units) Table 50. North America Huntington Disease Medications Sales by Country (2027-2032) & (K Units) Table 51. Europe Huntington Disease Medications Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 52. Europe Huntington Disease Medications Sales by Country (2021-2026) & (K Units) Table 53. Europe Huntington Disease Medications Sales by Country (2027-2032) & (K Units) Table 54. Asia Pacific Huntington Disease Medications Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Asia Pacific Huntington Disease Medications Sales by Country (2021-2026) & (K Units) Table 56. Asia Pacific Huntington Disease Medications Sales by Country (2027-2032) & (K Units) Table 57. South America, Middle East and Africa Huntington Disease Medications Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 58. South America, Middle East and Africa Huntington Disease Medications Sales by Country (2021-2026) & (K Units) Table 59. South America, Middle East and Africa Huntington Disease Medications Sales by Country (2027-2032) & (K Units) Table 60. Global Huntington Disease Medications Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Huntington Disease Medications Revenue by Region (2021-2026) & (US$ Million) Table 62. Global Huntington Disease Medications Revenue by Region (2027-2032) & (US$ Million) Table 63. Global Huntington Disease Medications Revenue Market Share by Region (2021-2026) Table 64. Global Huntington Disease Medications Revenue Market Share by Region (2027-2032) Table 65. Teva Company Information Table 66. Teva Business Overview Table 67. Teva Huntington Disease Medications Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Teva Huntington Disease Medications Product Portfolio Table 69. Teva Recent Development Table 70. Sandoz Company Information Table 71. Sandoz Business Overview Table 72. Sandoz Huntington Disease Medications Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Sandoz Huntington Disease Medications Product Portfolio Table 74. Sandoz Recent Development Table 75. Mylan Company Information Table 76. Mylan Business Overview Table 77. Mylan Huntington Disease Medications Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Mylan Huntington Disease Medications Product Portfolio Table 79. Mylan Recent Development Table 80. Zydus Company Information Table 81. Zydus Business Overview Table 82. Zydus Huntington Disease Medications Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Zydus Huntington Disease Medications Product Portfolio Table 84. Zydus Recent Development Table 85. Sun Pharmaceutical Company Information Table 86. Sun Pharmaceutical Business Overview Table 87. Sun Pharmaceutical Huntington Disease Medications Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Sun Pharmaceutical Huntington Disease Medications Product Portfolio Table 89. Sun Pharmaceutical Recent Development Table 90. Neurocrine Biosciences Company Information Table 91. Neurocrine Biosciences Business Overview Table 92. Neurocrine Biosciences Huntington Disease Medications Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. Neurocrine Biosciences Huntington Disease Medications Product Portfolio Table 94. Neurocrine Biosciences Recent Development Table 95. Lupin Company Information Table 96. Lupin Business Overview Table 97. Lupin Huntington Disease Medications Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 98. Lupin Huntington Disease Medications Product Portfolio Table 99. Lupin Recent Development Table 100. Hetero Company Information Table 101. Hetero Business Overview Table 102. Hetero Huntington Disease Medications Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 103. Hetero Huntington Disease Medications Product Portfolio Table 104. Hetero Recent Development Table 105. Dr. Reddy's Laboratories Company Information Table 106. Dr. Reddy's Laboratories Business Overview Table 107. Dr. Reddy's Laboratories Huntington Disease Medications Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 108. Dr. Reddy's Laboratories Huntington Disease Medications Product Portfolio Table 109. Dr. Reddy's Laboratories Recent Development Table 110. Chartwell Pharmaceuticals Company Information Table 111. Chartwell Pharmaceuticals Business Overview Table 112. Chartwell Pharmaceuticals Huntington Disease Medications Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 113. Chartwell Pharmaceuticals Huntington Disease Medications Product Portfolio Table 114. Chartwell Pharmaceuticals Recent Development Table 115. Bionpharma Company Information Table 116. Bionpharma Business Overview Table 117. Bionpharma Huntington Disease Medications Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 118. Bionpharma Huntington Disease Medications Product Portfolio Table 119. Bionpharma Recent Development Table 120. Bausch Health Company Information Table 121. Bausch Health Business Overview Table 122. Bausch Health Huntington Disease Medications Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 123. Bausch Health Huntington Disease Medications Product Portfolio Table 124. Bausch Health Recent Development Table 125. Apotex Company Information Table 126. Apotex Business Overview Table 127. Apotex Huntington Disease Medications Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 128. Apotex Huntington Disease Medications Product Portfolio Table 129. Apotex Recent Development Table 130. Actavis Laboratories Company Information Table 131. Actavis Laboratories Business Overview Table 132. Actavis Laboratories Huntington Disease Medications Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 133. Actavis Laboratories Huntington Disease Medications Product Portfolio Table 134. Actavis Laboratories Recent Development Table 135. Key Raw Materials Table 136. Raw Materials Key Suppliers Table 137. Huntington Disease Medications Distributors List Table 138. Huntington Disease Medications Customers List Table 139. Research Programs/Design for This Report Table 140. Authors List of This Report Table 141. Secondary Sources Table 142. Primary Sources List of Figures Figure 1. Huntington Disease Medications Product Image Figure 2. Global Huntington Disease Medications Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Huntington Disease Medications Market Size (2021-2032) & (US$ Million) Figure 4. Global Huntington Disease Medications Sales (2021-2032) & (K Units) Figure 5. Global Huntington Disease Medications Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Huntington Disease Medications Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Deutetrabenazine Image Figure 9. Tetrabenazine Image Figure 10. Valbenazine Image Figure 11. Others Image Figure 12. Global Huntington Disease Medications Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 13. Global Huntington Disease Medications Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Huntington Disease Medications Sales Market Share by Type (2021-2032) Figure 15. Global Huntington Disease Medications Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 16. Global Huntington Disease Medications Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Huntington Disease Medications Revenue Market Share by Type (2021-2032) Figure 18. Hospital and Clinic Image Figure 19. Pharmacy Image Figure 20. Other Image Figure 21. Global Huntington Disease Medications Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Huntington Disease Medications Sales Market Share 2021 VS 2025 VS 2032 Figure 23. Global Huntington Disease Medications Sales Market Share by Application (2021-2032) Figure 24. Global Huntington Disease Medications Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 25. Global Huntington Disease Medications Revenue Market Share 2021 VS 2025 VS 2032 Figure 26. Global Huntington Disease Medications Revenue Market Share by Application (2021-2032) Figure 27. North America Huntington Disease Medications Sales and Growth Rate (2021-2032) & (K Units) Figure 28. North America Huntington Disease Medications Sales Market Share by Country (2021-2032) Figure 29. U.S. Huntington Disease Medications Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Canada Huntington Disease Medications Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Mexico Huntington Disease Medications Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Europe Huntington Disease Medications Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Europe Huntington Disease Medications Sales Market Share by Country (2021-2032) Figure 34. Germany Huntington Disease Medications Sales and Growth Rate (2021-2032) & (K Units) Figure 35. France Huntington Disease Medications Sales and Growth Rate (2021-2032) & (K Units) Figure 36. U.K. Huntington Disease Medications Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Italy Huntington Disease Medications Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Netherlands Huntington Disease Medications Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Asia Pacific Huntington Disease Medications Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Asia Pacific Huntington Disease Medications Sales Market Share by Country (2021-2032) Figure 41. China Huntington Disease Medications Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Japan Huntington Disease Medications Sales and Growth Rate (2021-2032) & (K Units) Figure 43. South Korea Huntington Disease Medications Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Southeast Asia Huntington Disease Medications Sales and Growth Rate (2021-2032) & (K Units) Figure 45. India Huntington Disease Medications Sales and Growth Rate (2021-2032) & (K Units) Figure 46. Australia Huntington Disease Medications Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South America, Middle East and Africa Huntington Disease Medications Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South America, Middle East and Africa Huntington Disease Medications Sales Market Share by Country (2021-2032) Figure 49. Brazil Huntington Disease Medications Sales and Growth Rate (2021-2032) & (K Units) Figure 50. South Africa Huntington Disease Medications Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Saudi Arabia Huntington Disease Medications Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Turkey Huntington Disease Medications Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Argentina Huntington Disease Medications Sales and Growth Rate (2021-2032) & (K Units) Figure 54. UAE Huntington Disease Medications Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Egypt Huntington Disease Medications Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Chile Huntington Disease Medications Sales and Growth Rate (2021-2032) & (K Units) Figure 57. Global Huntington Disease Medications Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Global Huntington Disease Medications Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 59. North America Huntington Disease Medications Revenue (2021-2032) & (US$ Million) Figure 60. North America Huntington Disease Medications Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Huntington Disease Medications Revenue (2021-2032) & (US$ Million) Figure 62. Europe Huntington Disease Medications Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Huntington Disease Medications Revenue (2021-2032) & (US$ Million) Figure 64. Asia-Pacific Huntington Disease Medications Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. South America, Middle East and Africa Huntington Disease Medications Revenue (2021-2032) & (US$ Million) Figure 66. South America, Middle East and Africa Huntington Disease Medications Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Huntington Disease Medications Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Huntington Disease Medications Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Deutetrabenazine
  • Tetrabenazine
  • Valbenazine
  • Others
Applications
  • Hospital and Clinic
  • Pharmacy
  • Other
Companies covered
  • Teva
  • Sandoz
  • Mylan
  • Zydus
  • Sun Pharmaceutical
  • Neurocrine Biosciences
  • Lupin
  • Hetero
  • Dr. Reddy's Laboratories
  • Chartwell Pharmaceuticals
  • Bionpharma
  • Bausch Health
  • Apotex
  • Actavis Laboratories

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Huntington Disease Medications Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Huntington Disease Medications Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Huntington Disease Medications Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Huntington Disease Medications Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Huntington Disease Medications Market Dynamics
  1. 2.1 Huntington Disease Medications Industry Trends
  2. 2.2 Huntington Disease Medications Industry Drivers
  3. 2.3 Huntington Disease Medications Industry Opportunities and Challenges
  4. 2.4 Huntington Disease Medications Industry Restraints
3 Huntington Disease Medications Market by Manufacturers
  1. 3.1 Global Huntington Disease Medications Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Huntington Disease Medications Sales by Manufacturers (2021-2026)
  3. 3.3 Global Huntington Disease Medications Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Huntington Disease Medications Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Huntington Disease Medications Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Huntington Disease Medications Manufacturers, Product Type & Application
  7. 3.7 Global Huntington Disease Medications Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Huntington Disease Medications Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Huntington Disease Medications Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Huntington Disease Medications Tier 1, Tier 2, and Tier 3
4 Huntington Disease Medications Market by Type
  1. 4.1 Huntington Disease Medications Type Introduction
  2. 4.1.1 Deutetrabenazine
  3. 4.1.2 Tetrabenazine
  4. 4.1.3 Valbenazine
  5. 4.1.4 Others
  6. 4.2 Global Huntington Disease Medications Sales by Type
  7. 4.2.1 Global Huntington Disease Medications Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Huntington Disease Medications Sales by Type (2021-2032)
  9. 4.2.3 Global Huntington Disease Medications Sales Market Share by Type (2021-2032)
  10. 4.3 Global Huntington Disease Medications Revenue by Type
  11. 4.3.1 Global Huntington Disease Medications Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Huntington Disease Medications Revenue by Type (2021-2032)
  13. 4.3.3 Global Huntington Disease Medications Revenue Market Share by Type (2021-2032)
5 Huntington Disease Medications Market by Application
  1. 5.1 Huntington Disease Medications Application Introduction
  2. 5.1.1 Hospital and Clinic
  3. 5.1.2 Pharmacy
  4. 5.1.3 Other
  5. 5.2 Global Huntington Disease Medications Sales by Application
  6. 5.2.1 Global Huntington Disease Medications Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Huntington Disease Medications Sales by Application (2021-2032)
  8. 5.2.3 Global Huntington Disease Medications Sales Market Share by Application (2021-2032)
  9. 5.3 Global Huntington Disease Medications Revenue by Application
  10. 5.3.1 Global Huntington Disease Medications Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Huntington Disease Medications Revenue by Application (2021-2032)
  12. 5.3.3 Global Huntington Disease Medications Revenue Market Share by Application (2021-2032)
6 Global Huntington Disease Medications Sales by Region
  1. 6.1 Global Huntington Disease Medications Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Huntington Disease Medications Sales by Region (2021-2032)
  3. 6.2.1 Global Huntington Disease Medications Sales by Region (2021-2026)
  4. 6.2.2 Global Huntington Disease Medications Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Huntington Disease Medications Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Huntington Disease Medications Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Huntington Disease Medications Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Huntington Disease Medications Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Huntington Disease Medications Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Huntington Disease Medications Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Huntington Disease Medications Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Huntington Disease Medications Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Huntington Disease Medications Revenue by Region
  1. 7.1 Global Huntington Disease Medications Revenue by Region
  2. 7.1.1 Global Huntington Disease Medications Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Huntington Disease Medications Revenue by Region (2021-2026)
  4. 7.1.3 Global Huntington Disease Medications Revenue by Region (2027-2032)
  5. 7.1.4 Global Huntington Disease Medications Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Huntington Disease Medications Revenue (2021-2032)
  8. 7.2.2 North America Huntington Disease Medications Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Huntington Disease Medications Revenue (2021-2032)
  11. 7.3.2 Europe Huntington Disease Medications Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Huntington Disease Medications Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Huntington Disease Medications Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Huntington Disease Medications Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Huntington Disease Medications Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Teva
  2. 8.1.1 Teva Company Information
  3. 8.1.2 Teva Business Overview
  4. 8.1.3 Teva Huntington Disease Medications Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Teva Huntington Disease Medications Product Portfolio
  6. 8.1.5 Teva Recent Developments
  7. 8.2 Sandoz
  8. 8.2.1 Sandoz Company Information
  9. 8.2.2 Sandoz Business Overview
  10. 8.2.3 Sandoz Huntington Disease Medications Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Sandoz Huntington Disease Medications Product Portfolio
  12. 8.2.5 Sandoz Recent Developments
  13. 8.3 Mylan
  14. 8.3.1 Mylan Company Information
  15. 8.3.2 Mylan Business Overview
  16. 8.3.3 Mylan Huntington Disease Medications Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Mylan Huntington Disease Medications Product Portfolio
  18. 8.3.5 Mylan Recent Developments
  19. 8.4 Zydus
  20. 8.4.1 Zydus Company Information
  21. 8.4.2 Zydus Business Overview
  22. 8.4.3 Zydus Huntington Disease Medications Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Zydus Huntington Disease Medications Product Portfolio
  24. 8.4.5 Zydus Recent Developments
  25. 8.5 Sun Pharmaceutical
  26. 8.5.1 Sun Pharmaceutical Company Information
  27. 8.5.2 Sun Pharmaceutical Business Overview
  28. 8.5.3 Sun Pharmaceutical Huntington Disease Medications Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Sun Pharmaceutical Huntington Disease Medications Product Portfolio
  30. 8.5.5 Sun Pharmaceutical Recent Developments
  31. 8.6 Neurocrine Biosciences
  32. 8.6.1 Neurocrine Biosciences Company Information
  33. 8.6.2 Neurocrine Biosciences Business Overview
  34. 8.6.3 Neurocrine Biosciences Huntington Disease Medications Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Neurocrine Biosciences Huntington Disease Medications Product Portfolio
  36. 8.6.5 Neurocrine Biosciences Recent Developments
  37. 8.7 Lupin
  38. 8.7.1 Lupin Company Information
  39. 8.7.2 Lupin Business Overview
  40. 8.7.3 Lupin Huntington Disease Medications Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Lupin Huntington Disease Medications Product Portfolio
  42. 8.7.5 Lupin Recent Developments
  43. 8.8 Hetero
  44. 8.8.1 Hetero Company Information
  45. 8.8.2 Hetero Business Overview
  46. 8.8.3 Hetero Huntington Disease Medications Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Hetero Huntington Disease Medications Product Portfolio
  48. 8.8.5 Hetero Recent Developments
  49. 8.9 Dr. Reddy's Laboratories
  50. 8.9.1 Dr. Reddy's Laboratories Company Information
  51. 8.9.2 Dr. Reddy's Laboratories Business Overview
  52. 8.9.3 Dr. Reddy's Laboratories Huntington Disease Medications Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Dr. Reddy's Laboratories Huntington Disease Medications Product Portfolio
  54. 8.9.5 Dr. Reddy's Laboratories Recent Developments
  55. 8.10 Chartwell Pharmaceuticals
  56. 8.10.1 Chartwell Pharmaceuticals Company Information
  57. 8.10.2 Chartwell Pharmaceuticals Business Overview
  58. 8.10.3 Chartwell Pharmaceuticals Huntington Disease Medications Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Chartwell Pharmaceuticals Huntington Disease Medications Product Portfolio
  60. 8.10.5 Chartwell Pharmaceuticals Recent Developments
  61. 8.11 Bionpharma
  62. 8.11.1 Bionpharma Company Information
  63. 8.11.2 Bionpharma Business Overview
  64. 8.11.3 Bionpharma Huntington Disease Medications Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Bionpharma Huntington Disease Medications Product Portfolio
  66. 8.11.5 Bionpharma Recent Developments
  67. 8.12 Bausch Health
  68. 8.12.1 Bausch Health Company Information
  69. 8.12.2 Bausch Health Business Overview
  70. 8.12.3 Bausch Health Huntington Disease Medications Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Bausch Health Huntington Disease Medications Product Portfolio
  72. 8.12.5 Bausch Health Recent Developments
  73. 8.13 Apotex
  74. 8.13.1 Apotex Company Information
  75. 8.13.2 Apotex Business Overview
  76. 8.13.3 Apotex Huntington Disease Medications Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Apotex Huntington Disease Medications Product Portfolio
  78. 8.13.5 Apotex Recent Developments
  79. 8.14 Actavis Laboratories
  80. 8.14.1 Actavis Laboratories Company Information
  81. 8.14.2 Actavis Laboratories Business Overview
  82. 8.14.3 Actavis Laboratories Huntington Disease Medications Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Actavis Laboratories Huntington Disease Medications Product Portfolio
  84. 8.14.5 Actavis Laboratories Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Huntington Disease Medications Value Chain Analysis
  2. 9.1.1 Huntington Disease Medications Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Huntington Disease Medications Production Mode & Process
  6. 9.2 Huntington Disease Medications Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Huntington Disease Medications Distributors
  9. 9.2.3 Huntington Disease Medications Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst